Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Manufacturing

Business briefs: Bayer, FDA, Ranbaxy

May 15, 2013

Bayer's prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations
 

Navidea deploying MSLs in launch of new diagnostic agent

May 02, 2013

Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.
 

Excedrin relaunch features Sparks, "Thank yous" from migraine sufferers

November 21, 2012

Novartis is hyping its relaunch of Excedrin with a celebrity spokesperson, a migraine app and a survey of women migraine sufferers - along with print and out-of-home ads, radio promotions, direct mail and social media.
 

Company news: Eli Lilly and Novartis

October 31, 2012

Eli Lilly to add manufacturing capacity in Indianapolis, Novartis invests more in Singapore
 

Op/Ed: Meningitis crisis and the threat to pharma

October 10, 2012

The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding.
 

Company news: UBM Medica, Bristol-Myers Squibb

July 11, 2012

UBM Medica adds a third iPad app, BMS expands in Puerto Rico.
 

Company news: GlaxoSmithKline, AstraZeneca, Nature Publishing

March 22, 2012

GlaxoSmithKline is building its first new UK factory in almost 40 years, the firm said, spurring jobs while breaking new ground at some of its current locations.
 

Sanofi braces for patent cliff impact

February 09, 2012

Sanofi is girding itself for an ugly year, forecasting a 12%-15% drop in business earnings per share for 2012 as the company absorbs the loss of patent exclusivity on a stable of drugs that brought in more than €4 billion last year.
 

J&J says no shakeup at McNeil Consumer Healthcare unit

February 01, 2012

J&J is pushing back hard against a Wall Street Journal article suggesting that a pair of retirements and a promotion are part of a corporate shakeup of its recall-plagued McNeil Consumer Healthcare division.
 
  

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Accountable Care Organizations ACOs Acquisition Advertising App Cardiovascular Clinical Trial Diabetes FDA Generic Generic Drugs Health Affairs Healthcare Reform Journal Articles Layoffs Mobile Obesity Oncology OPDP Patent Cliff Patents Research & Development Rheumatology Social Media Women's Health

Topics

Consumer
Continuing Medical Education (CME)
Digital
Direct to Consumer
Direct to Patient
Downsize
Education & Awareness
FDA
Label
Legal
Online
Over the Counter
Promotion
Public Relations
Sales Force
Trend

Sectors

Agency
Biotech
Government
Media
Pharmaceutical
Suppliers & Vendors

Verticals

Business
Marketing & Communications
Regulatory
Research & Development

Events

Awards

Archives

Issue Archive
Sitemap
 

© 2013 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions